Logo image of IVF

INVO FERTILITY INC (IVF) Stock Price, Quote, News and Overview

NASDAQ:IVF - Nasdaq - US44984F6097 - Common Stock - Currency: USD

1.72  -0.01 (-0.58%)

After market: 1.93 +0.21 (+12.21%)

IVF Quote, Performance and Key Statistics

INVO FERTILITY INC

NASDAQ:IVF (8/13/2025, 8:16:47 PM)

After market: 1.93 +0.21 (+12.21%)

1.72

-0.01 (-0.58%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap1.60M
Shares930.00K
Float840.00K
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)11-17 2025-11-17
IPO11-11 2008-11-11


IVF short term performance overview.The bars show the price performance of IVF in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -20 -40 -60

IVF long term performance overview.The bars show the price performance of IVF in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of IVF is 1.72 USD. In the past month the price decreased by -30.07%.

INVO FERTILITY INC / IVF Daily stock chart

IVF Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 26.41 225.14B
ISRG INTUITIVE SURGICAL INC 59.92 172.91B
BSX BOSTON SCIENTIFIC CORP 36.22 151.64B
SYK STRYKER CORP 29.49 144.82B
MDT MEDTRONIC PLC 16.89 119.04B
BDX BECTON DICKINSON AND CO 13.73 56.16B
IDXX IDEXX LABORATORIES INC 55.28 53.39B
EW EDWARDS LIFESCIENCES CORP 30.23 45.57B
RMD RESMED INC 30.19 42.27B
GEHC GE HEALTHCARE TECHNOLOGY 16.17 34.49B
DXCM DEXCOM INC 47.04 31.35B
PHG KONINKLIJKE PHILIPS NVR- NY 16.34 26.28B

About IVF

Company Profile

IVF logo image INVO Fertility Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Sarasota, Florida and currently employs 28 full-time employees. The company went IPO on 2008-11-11. INVO Fertility Inc., formerly NAYA Biosciences, Inc., is a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition, and operation of fertility clinics. The company focuses on operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, vitro fertilization (IVF) clinics. The company has two operational INVO Centers in the United States and one IVF clinic. The company is also engaged in the sale and distribution of its INVOcell technology solution into third-party owned and operated fertility clinics. The INVOcell is a proprietary medical device that allow fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a natural, intimate, and affordable experience.

Company Info

INVO FERTILITY INC

5582 Broadcast Court

Sarasota FLORIDA US

Employees: 28

IVF Company Website

IVF Investor Relations

Phone: 19788789505

INVO FERTILITY INC / IVF FAQ

What is the stock price of INVO FERTILITY INC today?

The current stock price of IVF is 1.72 USD. The price decreased by -0.58% in the last trading session.


What is the ticker symbol for INVO FERTILITY INC stock?

The exchange symbol of INVO FERTILITY INC is IVF and it is listed on the Nasdaq exchange.


On which exchange is IVF stock listed?

IVF stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for INVO FERTILITY INC stock?

5 analysts have analysed IVF and the average price target is 18.36 USD. This implies a price increase of 967.44% is expected in the next year compared to the current price of 1.72. Check the INVO FERTILITY INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is INVO FERTILITY INC worth?

INVO FERTILITY INC (IVF) has a market capitalization of 1.60M USD. This makes IVF a Nano Cap stock.


How many employees does INVO FERTILITY INC have?

INVO FERTILITY INC (IVF) currently has 28 employees.


What are the support and resistance levels for INVO FERTILITY INC (IVF) stock?

INVO FERTILITY INC (IVF) has a resistance level at 1.88. Check the full technical report for a detailed analysis of IVF support and resistance levels.


Is INVO FERTILITY INC (IVF) expected to grow?

The Revenue of INVO FERTILITY INC (IVF) is expected to grow by 10.02% in the next year. Check the estimates tab for more information on the IVF EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy INVO FERTILITY INC (IVF) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does INVO FERTILITY INC (IVF) stock pay dividends?

IVF does not pay a dividend.


When does INVO FERTILITY INC (IVF) report earnings?

INVO FERTILITY INC (IVF) will report earnings on 2025-11-17.


What is the Price/Earnings (PE) ratio of INVO FERTILITY INC (IVF)?

INVO FERTILITY INC (IVF) does not have a PE ratio as the earnings reported over the last twelve months were negative (-69.62).


IVF Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

IVF Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to IVF. IVF may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

IVF Financial Highlights

Over the last trailing twelve months IVF reported a non-GAAP Earnings per Share(EPS) of -69.62. The EPS decreased by -309.05% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -79.24%
ROE -343.9%
Debt/Equity 0.27
Chartmill High Growth Momentum
EPS Q2Q%-1857.29%
Sales Q2Q%3.86%
EPS 1Y (TTM)-309.05%
Revenue 1Y (TTM)55.2%

IVF Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 80% to IVF. The Buy consensus is the average rating of analysts ratings from 5 analysts.

For the next year, analysts expect an EPS growth of 92.84% and a revenue growth 10.02% for IVF


Ownership
Inst Owners4.1%
Ins Owners0.28%
Short Float %N/A
Short Ratio0.07
Analysts
Analysts80
Price Target18.36 (967.44%)
EPS Next Y92.84%
Revenue Next Year10.02%